Detalles de la búsqueda
1.
Hybrid human-porcine factor VIII proteins partially escape the inhibitory effects of anti-factor VIII inhibitor alloantibodies having A2 or C2 domain specificity.
Haemophilia
; 30(1): 140-150, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38058226
2.
How to recover lost vaccine acceptance? A multi-center survey on HPV vaccine acceptance in Japan.
J Infect Chemother
; 27(3): 445-449, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-33127289
3.
Longitudinal dynamic changes in factor VIII inhibitor titers in patients with hemophilia A and inhibitors receiving emicizumab prophylaxis.
Int J Hematol
; 118(6): 690-698, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37803190
4.
Activated partial thromboplastin time-based clot waveform analysis enables measurement of very low levels of factor IX activity in patients with severe hemophilia B.
Int J Hematol
; 116(5): 778-786, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-35864291
5.
Comparisons of global coagulation potential and bleeding episodes in emicizumab-treated hemophilia A patients and mild hemophilia A patients.
Int J Hematol
; 115(4): 489-498, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35043383
6.
Clot waveform analysis for perioperative hemostatic monitoring of arthroscopic synovectomy in a pediatric patient with hemophilia A and inhibitor receiving emicizumab prophylaxis.
Int J Hematol
; 113(6): 930-935, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-33566316
7.
Ex Vivo Prediction of Comprehensive Coagulation Potential Using Simulated Blood Concentrations of Emicizumab in Patients with Acquired Hemophilia A.
Thromb Haemost
; 121(10): 1289-1298, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-33641138
8.
Hemostatic assessment of combined anticoagulant therapy using warfarin and prothrombin complex concentrates in a case of severe protein C deficiency.
Int J Hematol
; 109(6): 650-656, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-30963470
Resultados
1 -
8
de 8
1
Próxima >
>>